Controlled Release

April 18 - 19, 2016 - London UK

SMi Group

vtrinh@smi-online.co.uk
Phone:+44 (0) 20 7827 6140

SMi's 13th annual Controlled Release conference will provide the ideal platform to receive updates on the latest innovations to accelerate commercialisation, as well as developments in the regulatory landscape to ensure strict compliance. The two-day programme is packed with unmissable case studies provided by GlaxoSmithKline, MHRA, US FDA, Ipsen, Novo Nordisk, MedImmune, AstraZeneca, Lundbeck, Merck, UCB Pharma, Critical Pharmaceuticals, Kashiv Pharma, Diurnal and more.

More Information